B+
Bull case
20%
Probability
Target price
$256.20
+145.0% vs current
IRTC
iRhythmDNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$218.60
+109.1% vs current
B-
Bear case
20%
Probability
Target price
$175.00
+67.4% vs current
AI sentiment snapshot
Latest data as of 2026-01-07
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Market commentary is cautiously positive: several consensus price-target aggregates show a constructive mean vs. the anchor, but dispersion is wide and execution risk remains [#SERP-2]. Recent analyst coverage skews toward Buy/Strong Buy in aggregates, reflecting optimism on growth and AI-enabled product adoption [#SERP-1].
RankAlpha Sentiment AI - 2026-01-07
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-04-07catalystUpcoming quarterly earnings (Q4/2025) and guidanceHigh impact
Quarterly results and management guidance may reprice shares; consensus analyst targets imply upside vs. current anchor, making the print a near-term catalyst for revision [#SERP-2].
2026-06-30eventCommercial rollout/expansion of AI-driven arrhythmia toolsHigh impact
Broader adoption or a material commercial update for its AI/diagnostic platform could drive durable revenue growth; date is assumed conservatively as end of disclosed rollout window where only a window is public/uncertain [#SERP-4].
2027-01-07catalystReimbursement/market-share gains over 12 monthsHigh impact
Sustained uptake, favorable reimbursement decisions, or partnerships could materially expand TAM and push valuation higher over a 12 -month horizon [#SERP-1].
Recommendation
N/A
No formal recommendation provided.
As of 2026-01-07 • Updated nightlySource: Internal modelMethodology